Genentech Announces Industry-Leading Brain Health Research C

Genentech Announces Industry-Leading Brain Health Research Collaborations and Latest Data Across Neuroscience Medicines at AAN 2023 Annual Meeting

–– Roche, Genentech and partners embark on global prevalence research, trend-spotting with digital analysis, and telehealth initiatives to assess & address deterrents to brain health... | June 18, 2023

Related Keywords

Canada , Boston , Massachusetts , United States , United Kingdom , California , South San Francisco , Russia , Japan , South Korea , American , British , Levi Garraway , Gregorya Rippon , Brainpower Brain Patient Outcomes With Experience Research , British Pharmacological Society , Roche Group , Office Of Orphan Products Development , European Union , Brain Health Initiative , Drug Administration , Neuroscience Patient Experience Research , Institute For Health Metrics , European Medicines Agency , American Academy Of Neurology , Global Product Development , Brain Health Collaborative , Genentech , Commitment To Advancing Understanding Of Brain Health , Toddler Development , Society For Medicines Research , University Of Washington , Brain Health Atlas , Health Metrics , Cleveland Clinic , American Academy , Annual Meeting , Global Product , Advancing Understanding , Brain Health , Policy Hub , Neuroscience Patient Experience , Brain Patient Outcomes With Experience Research , Vice President , Chief Medical Partner , Neuroscience Pipeline , Brain Shuttle , Breakthrough Therapy Designation , Orphan Drug Designation , Drug Discovery , Medicines Research , Gross Motor Scale , Bayley Scales , Third Edition , Motor Function Measure , Orphan Products Development , Drug Designation , Important Safety , Multifocal Leukoencephalopathy , Ocrevus Pregnancy , Prescribing Information , Evrysdi Pregnancy Registry , Important Safety Information ,

© 2025 Vimarsana